Filing Details
- Accession Number:
- 0001651844-15-000008
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-12-18 17:46:33
- Reporting Period:
- 2015-12-14
- Filing Date:
- 2015-12-18
- Accepted Time:
- 2015-12-18 17:46:33
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1018735 | Nymox Pharmaceutical Corp | NYMX | In Vitro & In Vivo Diagnostic Substances (2835) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1651844 | George James Robinson | 10 East Lee Street Suite 2705 Baltimore MD 21202 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-12-14 | 3,188 | $3.53 | 2,427,550 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2015-12-14 | 10,000 | $3.47 | 2,437,550 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2015-12-14 | 10,000 | $3.42 | 2,447,550 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2015-12-15 | 9,946 | $3.40 | 2,457,496 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2015-12-15 | 10,000 | $3.43 | 2,467,496 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2015-12-16 | 200 | $3.46 | 2,467,696 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2015-12-17 | 8,600 | $3.97 | 2,476,296 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2015-12-17 | 1,300 | $3.96 | 2,477,596 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2015-12-17 | 100 | $3.95 | 2,477,696 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2015-12-18 | 10,000 | $3.68 | 2,487,696 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 45,050 | Indirect | Trust |
Common Stock | 45,050 | Indirect | Trust |
Common Stock | 45,050 | Indirect | Trust |
Common Stock | 45,050 | Indirect | Trust |
Common Stock | 45,050 | Indirect | Trust |
Common Stock | 45,050 | Indirect | Trust |
Common Stock | 45,050 | Indirect | Trust |
Common Stock | 45,050 | Indirect | Trust |
Common Stock | 45,050 | Indirect | Trust |
Common Stock | 45,050 | Indirect | Trust |